Subscribe
Sign In
Menu
Search
Financial Times
myFT
Search the
FT
Search
Search the
FT
Search
Close
Home
World
US
Companies
Tech
Markets
Climate
Opinion
Lex
Work & Careers
Life & Arts
How To Spend It
Sign In
Subscribe
Markets
Markets Data
Equities
Equities Screener
Sectors & Industries
Company Announcements
Director Dealings
World Markets
Financial Times
Close
International Edition
UK Edition
Search the
FT
Search
Top sections
Home
Show more World link
World
Middle East war
Global Economy
UK
US
China
Africa
Asia Pacific
Emerging Markets
Europe
War in Ukraine
Americas
Middle East & North Africa
Show more US link
US
US Economy
US Companies
US Politics & Policy
Show more Companies link
Companies
Energy
Financials
Health
Industrials
Media
Professional Services
Retail & Consumer
Tech Sector
Telecoms
Transport
Show more Tech link
Tech
Artificial intelligence
Semiconductors
Cyber Security
Social Media
Show more Markets link
Markets
Alphaville
Markets Data
Private markets
Equities
Bonds
Currencies
Commodities
Crypto
Monetary Policy Radar
Wealth Management
Moral Money
ETF Hub
Asset management
Climate
Show more Opinion link
Opinion
Columnists
The FT View
The Big Read
Lex
Obituaries
Letters
Lex
Show more Work & Careers link
Work & Careers
Business School Rankings
Business Education
Europe's Start-Up Hubs
Entrepreneurship
Recruitment
Business Books
Business Travel
Working It
Show more Life & Arts link
Life & Arts
Arts
Books
Food & Drink
FT Magazine
House & Home
Style
Puzzles
Travel
FT Globetrotter
Show more Personal Finance link
Personal Finance
Property & Mortgages
Investments
Pensions
Tax
Banking & Savings
Advice & Comment
How To Spend It
Special Reports
FT recommends
Alphaville
FT Edit
Lunch with the FT
FT Globetrotter
#techAsia
Moral Money
Visual and data journalism
Newsletters
Video
Podcasts
News feed
FT Schools
FT Live Events
FT Forums
FT Leaders Academy
myFT
Portfolio
FT Digital Edition
Crossword
Our Apps
My Account
Sign In
Company Announcements
Latest announcements
Apply
Cancel
Filter announcements by
Company
●
Index
View announcements for companies within...
Dow Jones Industrial Average
FTSE 100
FTSE 250
FTSE 350 ACT
FTSE All Share
FTSE Eurofirst 300
NASDAQ Composite
NYSE Composite
S&P 500
Headline contains
●
Release contains
Date range:
Last 24 hours
Last 7 days
Last 28 days
Last 12 months
Custom date
From
To
Sources:
GlobeNewswire
LSE Regulatory News Service
Business Wire press releases
Canada Wire press releases
PR Newswire press releases
EQS Newswire
Countries:
Filter by country
Austria
Belgium
Bosnia and Herzegovina
Croatia
Cyprus
Estonia
Czech Republic
Finland
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Macedonia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Russia
Slovakia
Spain
Sweden
Switzerland
United States
United Kingdom
Turkey
Languages:
Filter by language
Danish
English
Estonian
Finnish
Icelandic
Latvian
Lithuanian
Swedish
Reset filters
Companies:
Index:
Headline contains:
Release contains:
Date range:
Sources:
Countries:
Languages:
Reset filters
Date and time
Company
Headline
Source
29 Mar 2026
China XLX Fertiliser Ltd
1866:HKG
China XLX Announces 2025 Annual Results Deepening efforts in reducing costs, enhancing efficiency, strengthening competitiveness through differentiation and driving marketing transformation
EQS Newswire
29 Mar 2026
Novartis AG
NOVN:SWX
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
GlobeNewswire
28 Mar 2026
Amgen Inc
4332:HKG
Churchill Capital Corp XI
CCXIU:NMQ
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
PR Newswire
28 Mar 2026
Trip.com Group Ltd
CLV:FRA
INVESTOR ALERT: Trip.com Group Limited (TCOM) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
PR Newswire
28 Mar 2026
Eli Lilly and Co
LLY:NYQ
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
PR Newswire
28 Mar 2026
Incyte Corp
ICY:DUS
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Business Wire
28 Mar 2026
Takeda Pharmaceutical Co Ltd
4502:TYO
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
Business Wire
28 Mar 2026
Corcept Therapeutics Inc
HTD:FRA
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
Business Wire
28 Mar 2026
MoonLake Immunotherapeutics
MLTX:NAQ
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
GlobeNewswire
28 Mar 2026
Roivant Sciences Ltd
ROIV:NSQ
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
GlobeNewswire
28 Mar 2026
Biogen Inc
IDP:DUS
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
GlobeNewswire
28 Mar 2026
Canadabis Capital Inc
CANB:CVE
CANADABIS ANNOUNCES DELAY IN FILING OF SECOND QUARTER FINANCIAL STATEMENTS
Canada Newswire
28 Mar 2026
Atos SE
ATO:PAR
Decision of the US District Court for the Southern District of New York in the TriZetto re-trial
GlobeNewswire
28 Mar 2026
Atos SE
ATO:PAR
Décision du tribunal américain du district Sud de New York dans le cadre du nouveau procès TriZetto
GlobeNewswire
RNS announcements are delayed by up to an hour.
Fewer results
1
2
3
...
498
499
500
More results